Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ligand Pharma (LGND)
NASDAQ:LGND
Holding LGND?
Track your performance easily
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 51.81M | $ 41.53M | $ 30.98M | $ 28.10M | $ 32.87M |
| Gross Profit | $ 49.36M | $ 38.63M | $ 28.10M | $ 26.46M | $ 29.38M |
| EBIT | $ -6.34M | $ -65.39M | $ 113.59M | - | $ -12.14M |
| EBITDA | $ 2.79M | $ -56.28M | $ 122.35M | - | $ -3.60M |
| Net Income Common Stockholders | $ -7.17M | $ -50.64M | $ 86.14M | $ 18.19M | $ -10.27M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 219.64M | $ 226.93M | $ 310.59M | $ 170.31M | $ 190.50M |
| Total Assets | $ 954.87M | $ 866.40M | $ 913.87M | $ 787.22M | $ 769.23M |
| Total Debt | $ 7.36M | $ 7.58M | $ 6.19M | $ 6.17M | $ 6.33M |
| Net Debt | $ -212.29M | $ -219.35M | $ -304.40M | $ -164.14M | $ -184.17M |
| Total Liabilities | $ 113.69M | $ 91.21M | $ 107.35M | $ 86.30M | $ 101.33M |
| Stockholders Equity | $ 841.18M | $ 775.20M | $ 806.52M | $ 700.91M | $ 667.90M |
| Cash Flow | - | ||||
| Free Cash Flow | $ 35.93M | $ 12.91M | $ 18.63M | - | $ 7.16M |
| Operating Cash Flow | $ 36.53M | $ 13.31M | $ 18.73M | $ 8.06M | $ 7.65M |
| Investing Cash Flow | $ -46.51M | $ -54.76M | $ -3.77M | $ -10.28M | $ -19.50M |
| Financing Cash Flow | $ 55.08M | $ 9.49M | $ 12.18M | $ 5.32M | $ 3.27M |